How Scientists Are Finally Figuring Out Alzheimer’s For decades, research into Alzheimer's has been hampered by controversy, scandal, and stagnation.
The disease affects over 7 million Americans, remains incurable, and treatments are hindered by groupthink and systemic fraud. Amidst the darkness, however, there are finally signs that the field is turning a corner.
The emergence of two new drugs – lecanemab and donanemab – has sparked optimism in the scientific community.